micro-community-banner
Profile Image
  • Add Media
  • Saved

1yr
Major Advances in Diabetes Research and Treatment Unveiled at ADA Scientific Sessions

Dr. Robert Gabbay, Chief Scientific and Medical Officer of the American Diabetes Association, highlights key themes from this year’s ADA Scientific Sessions, including significant progress in obesity treatment, type 1 diabetes, technology, health disparities, and innovation. Notable studies, such as the FLOW trial on GLP-1 receptor agonists for kidney outcomes and the Surmount OSA study on sleep apnea, were discussed.

Dr. John Buse shared insights from the Catalyst Study, revealing a high prevalence of hypercortisolism in patients with difficult-to-control type 2 diabetes, potentially reshaping future screening and treatment guidelines.

Profile Image
  • 1yr
    Fascinating studies and gives us another armament to control DM, HTN ASVD , CKD hopefully in the near future thanks
  • Saved

1yr
Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options

Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options

Source : https://pubmed.ncbi.nlm.nih.gov/38156451/

Atrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke, heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both directly and indirectly, through...

Obesity drives atrial fibrillation through multiple mechanisms, worsening outcomes and impacting treatment efficacy. Weight loss improves AF risk and recurrence, highlighting the need for personalized management strategies.

Profile Image
  • Saved

1yr
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

Source : https://pubmed.ncbi.nlm.nih.gov/38078870/

ClinicalTrials.gov Identifier: NCT04660643.

Continued tirzepatide treatment effectively maintains and enhances initial weight loss in individuals with obesity, while withdrawal leads to significant weight regain.

Profile Image
  • Saved

1yr
Obesity and Inflammatory Factors in the Progression of Early-Onset Colorectal Cancer

Obesity and Inflammatory Factors in the Progression of Early-Onset Colorectal Cancer

Source : https://pubmed.ncbi.nlm.nih.gov/38611081/

Metabolic dysfunction associated with obesity leads to a chronic pro-inflammatory state with systemic effects, including the alteration of macrophage metabolism. Tumor-associated macrophages have been linked to the formation of cancer...

Understanding how obesity-related hormones and inflammatory mechanisms contribute to early-onset colorectal cancer can help develop new therapeutic targets and highlight the potential protective role of chemo-preventative agents like aspirin.

Profile Image
  • Saved

1yr
Obesity and body mass index: Past and future considerations in osteoarthritis research

Obesity and body mass index: Past and future considerations in osteoarthritis research

Source : https://pubmed.ncbi.nlm.nih.gov/38354848/

Obesity is an important topic for the osteoarthritis (OA) scientific community. However, the predominant use of body mass index (BMI) to define obesity in OA research is associated with uncertainties...

Future OA research should adopt alternative measures beyond BMI to accurately identify obesity, consider evolving obesity science, and minimize weight stigma to enhance health outcomes for those with or at risk for OA.

Profile Image